UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Madison Square Garden
MSGE
$3.62B
| $4.1M | ﹤0.01% |
102,683
+70,337
| +217% | +$2.48M |
|
1802
Universal Corp
UVV
$1.27B
| $4.1M | ﹤0.01% |
70,381
+33,423
| +90% | +$1.92M |
|
1803
Aurora
AUR
$13.8B
| $4.09M | ﹤0.01% |
781,253
-1,265,507
| -62% | -$7.94M |
|
1804
Equinox Gold
EQX
$13.5B
| $4.08M | ﹤0.01% |
709,692
-70,449
| -9% | -$458K |
|
1805
Icon
ICLR
$12.7B
| $4.08M | ﹤0.01% |
28,054
+3,347
| +14% | +$475K |
|
1806
Praxis Precision Medicines
PRAX
$10.1B
| $4.08M | ﹤0.01% |
96,945
+9,864
| +11% | +$376K |
|
1807
German American Bancorp
GABC
$1.9B
| $4.06M | ﹤0.01% |
105,503
+50,133
| +91% | +$1.88M |
|
1808
Protolabs
PRLB
$2.13B
| $4.06M | ﹤0.01% |
101,431
+22,240
| +28% | +$829K |
|
1809
Middlesex Water
MSEX
$1.1B
| $4.05M | ﹤0.01% |
74,779
+15,557
| +26% | +$921K |
|
1810
Bio-Rad Laboratories Class A
BIO
$9.42B
| $4.04M | ﹤0.01% |
16,749
-366,058
| -96% | -$86.5M |
|
1811
Westamerica Bancorp
WABC
$1.37B
| $4.04M | ﹤0.01% |
83,365
+19,314
| +30% | +$925K |
|
|
BOW
1812
Bowhead Specialty Holdings
BOW
$1.1B
| $4.03M | ﹤0.01% |
107,285
-10,082
| -9% | -$386K |
|
1813
REX American Resources
REX
$1.41B
| $4.02M | ﹤0.01% |
164,924
+436
| +0.3% | +$9.2K |
|
1814
Cannae Holdings
CNNE
$649M
| $4.01M | ﹤0.01% |
192,539
+20,472
| +12% | +$378K |
|
1815
Tenaris
TS
$26.8B
| $3.98M | ﹤0.01% |
106,460
-33,094
| -24% | -$1.13M |
|
1816
Sally Beauty Holdings
SBH
$1.58B
| $3.97M | ﹤0.01% |
428,658
+103,752
| +32% | +$894K |
|
1817
Xometry
XMTR
$5.34B
| $3.97M | ﹤0.01% |
117,378
+51,029
| +77% | +$1.5M |
|
1818
Crescent Energy
CRGY
$3.82B
| $3.97M | ﹤0.01% |
461,075
+216,619
| +89% | +$1.9M |
|
1819
NextNav
NN
$2.23B
| $3.96M | ﹤0.01% |
260,696
+125,818
| +93% | +$1.61M |
|
1820
Astrana Health
ASTH
$1.77B
| $3.94M | ﹤0.01% |
158,439
+54,333
| +52% | +$1.53M |
|
1821
Encore Capital Group
ECPG
$2.13B
| $3.93M | ﹤0.01% |
101,605
+23,140
| +29% | +$839K |
|
1822
BrightView Holdings
BV
$1.07B
| $3.93M | ﹤0.01% |
235,784
+64,710
| +38% | +$968K |
|
1823
Array Technologies
ARRY
$855M
| $3.92M | ﹤0.01% |
663,690
+111,715
| +20% | +$678K |
|
1824
Astec Industries
ASTE
$1.02B
| $3.9M | ﹤0.01% |
93,484
+27,907
| +43% | +$1.06M |
|
1825
Sprout Social
SPT
$621M
| $3.87M | ﹤0.01% |
184,899
+58,764
| +47% | +$1.25M |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.